Saroja Pharma Industries India Limited — Others, 20-10-2024: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Saroja Pharma Industries India Limited has submitted a certificate to the National Stock Exchange, confirming compliance with regulations regarding the dematerialization and rematerialization of securities for the quarter ending September 30, 2024. The confirmation was issued by KFIN Technologies Limited, the company's Registrar and Share Transfer Agent, affirming that all necessary details have been reported to the relevant stock exchanges.